跳至主要内容
临床试验/NCT05259280
NCT05259280已完成不适用

ASPIRE: An Observational Study of the Wellinks Solution Impact on Quality of Life and Clinical Outcomes in Patients With COPD

Convexity Scientific Inc4 个研究点 分布在 1 个国家目标入组 153 人开始时间: 2022年1月5日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
153
试验地点
4
主要终点
Patient-Reported Healthcare Resource Utilization (HRU)

研究概览

简要总结

The clinical objectives of this study are to determine whether utilization of the Wellinks COPD Solution can improve quality of life for patients with COPD, can reduce healthcare resource utilization over time, and can improve pulmonary function as measured by connected devices.

The nonclinical objectives of this study are to describe the experience of patients using the Wellinks Solution through the assessment of patient engagement with the solution, as well as by patient-reported satisfaction with the solution and their perceived value (e.g., willingness to pay). Qualitative feedback on the features and functionality of the Wellinks Solution will be solicited.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • COPD diagnosis (confirmed by the patient and assumed based on participation in COPD PPRN)
  • Home telephone (landline or mobile) and internet access
  • Smartphone: iPhone 6S or later model, running iOS 14.0 or later; Android 6 or later model
  • Proficient in English language
  • Living/staying in the United States throughout the study duration
  • Willing and able to comply with study requirements
  • Able to provide written informed consent

排除标准

  • Current participation in other interventional clinical trials
  • Current participation in a pulmonary rehabilitation program

结局指标

主要结局

Patient-Reported Healthcare Resource Utilization (HRU)

时间窗: 24 weeks

Measure of health resource utilization from period 12 to 24 weeks. Emergency room visits. Hospitalizations.

Modified Medical Research Council Dyspnea Scale (mMRC)

时间窗: Change from baseline to 24 weeks

Change in mMRC score. (0-4, 0 is best)

COPD Self-Efficacy Scale

时间窗: Change from baseline to 24 weeks

Change in COPD Self-Efficacy Scale

COPD Symptoms Assessment

时间窗: Change from baseline to 24 weeks

Change in self-reported symptoms as collected in the app.

次要结局

未报告次要终点

研究者

发起方
Convexity Scientific Inc
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验